Controlling diabetes: The need for intensive therapy and barriers in clinical management

Diabetes Research and Clinical Practice

Volumn 65, Issue SUPPL., 2004, Pages

  Ross, Stuart A ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Clinical management; Complications; Diabetes mellitus; Hypoglycemia; Therapy

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; HEMOGLOBIN A1C; INSULIN; METFORMIN; SULFONYLUREA;

DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INTENSIVE CARE; ORGANIZATION; PHYSICIAN; PREVALENCE; REVIEW; WEIGHT GAIN;

EID: 4143122171     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2004.07.006     Document Type: Article

References (40)

1. A.H. Mokdad, E.S. Ford, B.A. Bowman, W.H. Dietz, F. Vinicor, and V.S. Bales Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001 J. Am. Med. Assoc. 289 2003 76 79
2. H. King, R.E. Aubert, and W.H. Herman Global burden of diabetes, 1995-2025 Diab. Care 21 1998 1414 1431
3. National Diabetes Statistics Fact Sheet: General Information and National Estimates on Diabetes in the United States, National Institute of Diabetes & Digestive & Kidney Diseases, 2000.
4. American Diabetes Association Economic costs of diabetes in the US in 2002 Diab. Care 26 2003 917 932
5. K.G. Dawson, D. Gomes, H. Gerstein, J.F. Blanchard, and K.H. Kahler The economic cost of diabetes in Canada, 1998 25 2002 1303 1307
6. M.I. Harris Diabetes in America: epidemiology and scope of the problem Diab. Care 21 Suppl. 3 1998 C11 C14
7. www.diabetes.org/type-2-diabetes.jsp, 2002.
8. A.H. Mokdad, B.A. Bowman, E.S. Ford, F. Vinicor, J.S. Marks, and J.P. Koplan The continuing epidemics of obesity and diabetes in the United States J. Am. Med. Assoc. 286 2001 1195 1200
9. J.O. Hill, and J.C. Peters Environmental contributions to the obesity epidemic Science 280 1998 1371 1374
10. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus J. Am. Med. Assoc. 287 2002 2563 2569
11. Diabetes Control and Complications Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N. Engl. J. Med. 329 1993 977 986
12. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
13. Y. Ohkubo, H. Kishikawa, E. Araki, T. Miyata, S. Isami, and S. Motoyoshi Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study Diab. Res. Clin. Pract. 28 1995 103 117
14. American College of Endocrinology Consensus Statement on Guidelines for Glycemic Control, American College of Endocrinology, Endocr. Pract. 8 (Suppl. 1) (2002) 5-11.
15. I.M. Stratton, A.I. Adler, H.A.W. Neil, D.R. Matthews, S.E. Manley, and C.A. Cull Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): a prospective observational study Br. Med. J. 321 2000 405 412
16. L.P. Lowe, K. Liu, P. Greenland, B.E. Metzger, A.R. Dyer, and J. Stamler Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. The Chicago heart association detection project in industry study Diab. Care 20 1997 163 169
17. The DECODE Study Group, European Diabetes Epidemiology Group Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Collaborative analysis of diagnostic criteria in Europe Lancet 354 1999 617 621
18. American Diabetes Association Report of the expert committee on the diagnosis and classification of diabetes mellitus Diab. Care 24 Suppl. 1 2001 S5 S19
19. www.diabetes.ca/cpg2003/downloads/nutrition.pdf, Nutrition Therapy: Canadian Diabetes Association Clinical Guidelines Expert Committee, 2003.
20. R.J. Thomas, P.J. Palumbo, J.J. Melton III, V.L. Roger, J. Ransom, and P.C. O'Brien Trends in the mortality burden associated with diabetes mellitus Arch. Intern. Med. 163 2003 445 451
21. M.I. Harris, R.C. Eastman, C.C. Cowie, K.M. Flegal, and M.S. Eberhardt Racial and ethnic differences in glycemic control of adults with type 2 diabetes Diab. Care 22 1999 403 408
22. S.B. Harris, M. Stewart, J.B. Brown, S. Wetmore, C. Faulds, and S. Webster-Bogaert Type 2 diabetes in family practice. Room for improvement Can. Fam. Physician 49 2003 721 722 (728-730)
23. P. Winocour Effective diabetes care: a need for realistic targets Br. Med. J. 324 2002 1577 1580
24. P.E. Cryer, S.N. Davis, and H. Shamoon Hypoglycemia in diabetes Diab. Care 26 2003 1902 1912
25. M.W.J. Strachan, I.J. Deary, F.M.E. Ewing, and B.M. Frier Recovery of cognitive function and mood after severe hypoglycemia in adults with insulin-treated diabetes Diab. Care 23 2000 305 312
26. S.R. Heller, and P.E. Cryer Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans Diabetes 40 1991 223 226
27. T. Lingenfelser, W. Renn, U. Sommerwerck, M.F. Jung, U.W. Buettner, and H. Zaiser-Kaschel Compromised hormonal counterregulation, symptom awareness, and neurophysiological function after recurrent short-term episodes of insulin-induced hypoglycemia in IDDM patients Diabetes 42 1993 610 618
28. S.N. Davis, C. Shavers, R. Mosqueda-Garcia, and F. Costa Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans Diabetes 46 1997 1328 1335
29. F. Ovalle, C.G. Fanelli, D.S. Paramore, T. Hershey, S. Craft, and P.E. Cryer Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus Diabetes 47 1998 1472 1479
30. I. Bendtson, A. Kverneland, S. Pramming, and C. Binder Incidence of nocturnal hypoglycemia in insulin-dependent diabetic patients on intensive therapy Acta Med. Scand. 223 1988 543 548
31. P. King, M.-F. Kong, H. Parkin, I.A. Macdonald, and R.B. Tattersall Well-being, cerebral function, and physical fatigue after nocturnal hypoglycemia in IDDM Diab. Care 21 1998 341 345
32. K.A. Matyka Nocturnal hypoglycemia in children: the effects on cognitive function Diab. Nutr. Metab. 2002 2002 390 395
33. J.F. Yale, I. Begg, H. Gerstein, R. Houlden, H. Jones, and P. Maheux Canadian Diabetes Association Clinical Practice Guidelines for the prevention and management of hypoglycemia in diabetes Can. J. Diab. 26 2001 22 35
34. T. Veneman, A. Mitrakou, M. Mokan, P.E. Cryer, and J. Gerich Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia Diabetes 42 1993 1233 1237
35. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 854 865
36. S. Makimattila, K. Nikkila, and H. Yki-Jarvinen Causes of weight gain during insulin therapy with and without metformin in patients with non-insulin-dependent diabetes Diabetologia 42 1999 406 412
37. H. Yki-Jarvinen Combination therapies with insulin in type 2 diabetes Diab. Care 24 2001 758 767
38. I.E. Kelly, T.S. Han, K. Walsh, and M.E. Lean Effects of a thiazolidinedione compound on body fat and fat distribution in patients with type 2 diabetes Diab. Care 22 1999 288 293
39. L.S. Phillips, W.T. Branch, C.B. Cook, J.P. Doyle, I.M. El-Kebbi, and D.L. Gallina Clinical inertia Ann. Intern. Med. 135 2001 825 834
40. UK Prospective Diabetes Study Group Overview of 6 years' therapy of type II diabetes: a progressive disease (UKPDS 16) Diabetes 44 1995 1249 1258